How light can control neurons: The science behind the 2026 Nobel Prize in medicine

The 2026 Nobel Prize in Physiology or Medicine has been awarded jointly to Karl Deisseroth, Peter Hegemann and Georg Nagel for their discoveries concerning light-gated ion channels and optogenetics.

The Nobel Assembly at Karolinska Institutet announced the prize on October 5, opening the 2026 Nobel Prize announcements. The laureates' work provided scientists with a way to use light to control the activity of selected nerve cells, giving researchers a much more precise tool for investigating the brain and nervous system.

The prize money for the 2026 Nobel Prize is 12 million Swedish kronor, to be shared by the three laureates.

What is optogenetics?

Optogenetics combines genetics and optics to control the activity of specific cells using light.

The technique relies on light-sensitive proteins known as light-gated ion channels. These proteins can alter the flow of electrically charged ions across a cell membrane when exposed to particular wavelengths of light.

This gives researchers a way to influence the electrical activity of selected neurons rather than stimulating a large population of surrounding cells.

That precision is what made optogenetics particularly important for neuroscience.

How did the breakthrough happen?

The work behind optogenetics developed through several stages.

Peter Hegemann and Georg Nagel studied light-sensitive proteins found in microorganisms. Their research helped establish how channelrhodopsins, light-sensitive proteins, could make cells respond to light.

The discovery provided the biological tools needed to make cells controllable with light.

Karl Deisseroth subsequently helped translate this principle into neuroscience. He and his collaborators introduced genes encoding light-sensitive proteins into nerve cells, allowing those cells to respond to light.

In experiments, light could then be used to trigger activity in genetically targeted neurons. Deisseroth's work helped establish optogenetics as a powerful method for studying neural circuits in living animals.

Why was this such a major change in neuroscience?

Before optogenetics, researchers had fewer ways to manipulate individual groups of neurons with comparable precision.

Electrical stimulation can affect multiple nearby cells, while drugs can act on many cells carrying the relevant receptors.

Optogenetics provided another approach: researchers could genetically identify a particular population of neurons and then use light to control those cells.

This made it possible to investigate much more precisely how specific neural circuits contribute to behaviour and physiological processes.

What can scientists study with optogenetics?

The technique has become an important research tool for investigating neural circuits involved in processes such as:

• movement
• sensory processing
• learning and memory
• motivation and reward
• sleep
• fear and other behaviours

Researchers can activate or inhibit selected neural populations and then observe what happens.

This allows scientists to investigate not simply which neurons are active during a behaviour, but whether manipulating those neurons actually changes the behaviour.

Why are light-gated ion channels important?

Neurons communicate partly through electrical signals produced by the movement of ions across their membranes.

Light-gated ion channels provide researchers with a way to influence this process using light.

Different light-sensitive proteins can have different effects on cells. Depending on the protein used, illumination can increase or decrease neuronal activity.

This means optogenetics is not simply a method for “turning the brain on and off”. It is a toolkit that allows researchers to manipulate particular cell populations and neural pathways with considerable temporal precision.

Has optogenetics already become a treatment?

Optogenetics is primarily a research technology, rather than an established treatment for common neurological or psychiatric conditions.

Its greatest contribution so far has been helping scientists understand how neural circuits work and how their dysfunction may contribute to disease.

Research using optogenetics has been important in studying conditions and processes associated with disorders including Parkinson's disease, epilepsy, addiction and other neurological or psychiatric conditions.

However, findings from animal and laboratory studies should not be presented as proof that optogenetics can directly treat these disorders in routine clinical practice.

One of the most notable areas of translational research has been vision.

Researchers have investigated whether light-sensitive proteins can be introduced into retinal cells that remain in people with certain forms of blindness. The goal is to make surviving cells responsive to light and potentially restore some visual function.

Such approaches are part of experimental clinical research and should not be confused with a widely available cure for blindness.

Why the Nobel Prize matters

The Nobel recognition highlights a fundamental shift in neuroscience: scientists gained a method for moving from observing neural activity to experimentally controlling specific neural circuits.

That distinction is crucial.

If a particular group of neurons becomes active when an animal performs a behaviour, observation alone does not establish that those neurons cause the behaviour. By selectively manipulating the cells and observing the resulting effect, researchers can investigate causal relationships.

Optogenetics made such experiments possible with a level of precision that transformed modern neuroscience.

One of the striking aspects of the work is the path from basic biological discovery to neuroscience.

Hegemann and Nagel's work on light-sensitive proteins in microorganisms provided the molecular components. Deisseroth and other researchers then developed ways to use those components in neurons.

The result was a technology that connected discoveries in microbiology, genetics, optics and neuroscience.

What happens next?

The Nobel Prize does not mean that light-based control of the human brain is now a routine medical treatment.

Instead, the recognition reflects the scientific importance of the underlying technology and the research it has enabled.

Optogenetics continues to be used to investigate neural circuits and disease mechanisms, while researchers are exploring possible therapeutic applications, including approaches involving the nervous system and vision.

The longer-term significance may therefore lie not in a single treatment, but in the ability to understand the brain's complex circuitry with far greater precision.

The 2026 Nobel Prize in Physiology or Medicine recognises a discovery that changed how scientists investigate one of biology's most complicated systems.

By combining light-sensitive proteins with genetic targeting, researchers gained a way to manipulate selected neurons with unprecedented precision.

For neuroscience, that has meant a move from simply asking which brain cells are active to investigating what happens when specific cells are deliberately activated or inhibited.

That ability has made optogenetics one of the defining experimental technologies in modern neuroscience and laid important foundations for future research into neurological and psychiatric disease.